Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gilenya Market Growth 2022-2028

  • LP 4890949
  • 79 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gilenya will have significant change from previous year. According to our (LP Information) latest study, the global Gilenya market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gilenya market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Gilenya market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gilenya market, reaching US$ million by the year 2028. As for the Europe Gilenya landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gilenya players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gilenya market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

28 Capsules/Box

96 Capsules/Box

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Retail Pharmacy

Hospital Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gilenya Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gilenya by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gilenya by Country/Region, 2017, 2022 & 2028

2.2 Gilenya Segment by Type

2.2.1 28 Capsules/Box

2.2.2 96 Capsules/Box

2.3 Gilenya Sales by Type

2.3.1 Global Gilenya Sales Market Share by Type (2017-2022)

2.3.2 Global Gilenya Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gilenya Sale Price by Type (2017-2022)

2.4 Gilenya Segment by Application

2.4.1 Retail Pharmacy

2.4.2 Hospital Pharmacy

2.4.3 Other

2.5 Gilenya Sales by Application

2.5.1 Global Gilenya Sale Market Share by Application (2017-2022)

2.5.2 Global Gilenya Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gilenya Sale Price by Application (2017-2022)

3 Global Gilenya by Company

3.1 Global Gilenya Breakdown Data by Company

3.1.1 Global Gilenya Annual Sales by Company (2020-2022)

3.1.2 Global Gilenya Sales Market Share by Company (2020-2022)

3.2 Global Gilenya Annual Revenue by Company (2020-2022)

3.2.1 Global Gilenya Revenue by Company (2020-2022)

3.2.2 Global Gilenya Revenue Market Share by Company (2020-2022)

3.3 Global Gilenya Sale Price by Company

3.4 Key Manufacturers Gilenya Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gilenya Product Location Distribution

3.4.2 Players Gilenya Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gilenya by Geographic Region

4.1 World Historic Gilenya Market Size by Geographic Region (2017-2022)

4.1.1 Global Gilenya Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gilenya Annual Revenue by Geographic Region

4.2 World Historic Gilenya Market Size by Country/Region (2017-2022)

4.2.1 Global Gilenya Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gilenya Annual Revenue by Country/Region

4.3 Americas Gilenya Sales Growth

4.4 APAC Gilenya Sales Growth

4.5 Europe Gilenya Sales Growth

4.6 Middle East & Africa Gilenya Sales Growth

5 Americas

5.1 Americas Gilenya Sales by Country

5.1.1 Americas Gilenya Sales by Country (2017-2022)

5.1.2 Americas Gilenya Revenue by Country (2017-2022)

5.2 Americas Gilenya Sales by Type

5.3 Americas Gilenya Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gilenya Sales by Region

6.1.1 APAC Gilenya Sales by Region (2017-2022)

6.1.2 APAC Gilenya Revenue by Region (2017-2022)

6.2 APAC Gilenya Sales by Type

6.3 APAC Gilenya Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gilenya by Country

7.1.1 Europe Gilenya Sales by Country (2017-2022)

7.1.2 Europe Gilenya Revenue by Country (2017-2022)

7.2 Europe Gilenya Sales by Type

7.3 Europe Gilenya Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gilenya by Country

8.1.1 Middle East & Africa Gilenya Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gilenya Revenue by Country (2017-2022)

8.2 Middle East & Africa Gilenya Sales by Type

8.3 Middle East & Africa Gilenya Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gilenya

10.3 Manufacturing Process Analysis of Gilenya

10.4 Industry Chain Structure of Gilenya

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gilenya Distributors

11.3 Gilenya Customer

12 World Forecast Review for Gilenya by Geographic Region

12.1 Global Gilenya Market Size Forecast by Region

12.1.1 Global Gilenya Forecast by Region (2023-2028)

12.1.2 Global Gilenya Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gilenya Forecast by Type

12.7 Global Gilenya Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Gilenya Product Offered

13.1.3 Novartis Gilenya Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Gilenya Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gilenya Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 28 Capsules/Box

Table 4. Major Players of 96 Capsules/Box

Table 5. Global Gilenya Sales by Type (2017-2022) & (K Units)

Table 6. Global Gilenya Sales Market Share by Type (2017-2022)

Table 7. Global Gilenya Revenue by Type (2017-2022) & ($ million)

Table 8. Global Gilenya Revenue Market Share by Type (2017-2022)

Table 9. Global Gilenya Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Gilenya Sales by Application (2017-2022) & (K Units)

Table 11. Global Gilenya Sales Market Share by Application (2017-2022)

Table 12. Global Gilenya Revenue by Application (2017-2022)

Table 13. Global Gilenya Revenue Market Share by Application (2017-2022)

Table 14. Global Gilenya Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Gilenya Sales by Company (2020-2022) & (K Units)

Table 16. Global Gilenya Sales Market Share by Company (2020-2022)

Table 17. Global Gilenya Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Gilenya Revenue Market Share by Company (2020-2022)

Table 19. Global Gilenya Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Gilenya Producing Area Distribution and Sales Area

Table 21. Players Gilenya Products Offered

Table 22. Gilenya Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Gilenya Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Gilenya Sales Market Share Geographic Region (2017-2022)

Table 27. Global Gilenya Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Gilenya Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Gilenya Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Gilenya Sales Market Share by Country/Region (2017-2022)

Table 31. Global Gilenya Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Gilenya Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Gilenya Sales by Country (2017-2022) & (K Units)

Table 34. Americas Gilenya Sales Market Share by Country (2017-2022)

Table 35. Americas Gilenya Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Gilenya Revenue Market Share by Country (2017-2022)

Table 37. Americas Gilenya Sales by Type (2017-2022) & (K Units)

Table 38. Americas Gilenya Sales Market Share by Type (2017-2022)

Table 39. Americas Gilenya Sales by Application (2017-2022) & (K Units)

Table 40. Americas Gilenya Sales Market Share by Application (2017-2022)

Table 41. APAC Gilenya Sales by Region (2017-2022) & (K Units)

Table 42. APAC Gilenya Sales Market Share by Region (2017-2022)

Table 43. APAC Gilenya Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Gilenya Revenue Market Share by Region (2017-2022)

Table 45. APAC Gilenya Sales by Type (2017-2022) & (K Units)

Table 46. APAC Gilenya Sales Market Share by Type (2017-2022)

Table 47. APAC Gilenya Sales by Application (2017-2022) & (K Units)

Table 48. APAC Gilenya Sales Market Share by Application (2017-2022)

Table 49. Europe Gilenya Sales by Country (2017-2022) & (K Units)

Table 50. Europe Gilenya Sales Market Share by Country (2017-2022)

Table 51. Europe Gilenya Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Gilenya Revenue Market Share by Country (2017-2022)

Table 53. Europe Gilenya Sales by Type (2017-2022) & (K Units)

Table 54. Europe Gilenya Sales Market Share by Type (2017-2022)

Table 55. Europe Gilenya Sales by Application (2017-2022) & (K Units)

Table 56. Europe Gilenya Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Gilenya Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Gilenya Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Gilenya Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Gilenya Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Gilenya Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Gilenya Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Gilenya Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Gilenya Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Gilenya

Table 66. Key Market Challenges & Risks of Gilenya

Table 67. Key Industry Trends of Gilenya

Table 68. Gilenya Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Gilenya Distributors List

Table 71. Gilenya Customer List

Table 72. Global Gilenya Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Gilenya Sales Market Forecast by Region

Table 74. Global Gilenya Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Gilenya Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Gilenya Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Gilenya Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Gilenya Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Gilenya Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Gilenya Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Gilenya Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Gilenya Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Gilenya Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Gilenya Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Gilenya Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Gilenya Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Gilenya Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Gilenya Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Gilenya Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Gilenya Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Gilenya Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis Basic Information, Gilenya Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis Gilenya Product Offered

Table 94. Novartis Gilenya Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Novartis Main Business

Table 96. Novartis Latest Developments

List of Figures

Figure 1. Picture of Gilenya

Figure 2. Gilenya Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gilenya Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gilenya Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gilenya Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 28 Capsules/Box

Figure 10. Product Picture of 96 Capsules/Box

Figure 11. Global Gilenya Sales Market Share by Type in 2021

Figure 12. Global Gilenya Revenue Market Share by Type (2017-2022)

Figure 13. Gilenya Consumed in Retail Pharmacy

Figure 14. Global Gilenya Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 15. Gilenya Consumed in Hospital Pharmacy

Figure 16. Global Gilenya Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 17. Gilenya Consumed in Other

Figure 18. Global Gilenya Market: Other (2017-2022) & (K Units)

Figure 19. Global Gilenya Sales Market Share by Application (2017-2022)

Figure 20. Global Gilenya Revenue Market Share by Application in 2021

Figure 21. Gilenya Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Gilenya Revenue Market Share by Company in 2021

Figure 23. Global Gilenya Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Gilenya Revenue Market Share by Geographic Region in 2021

Figure 25. Global Gilenya Sales Market Share by Region (2017-2022)

Figure 26. Global Gilenya Revenue Market Share by Country/Region in 2021

Figure 27. Americas Gilenya Sales 2017-2022 (K Units)

Figure 28. Americas Gilenya Revenue 2017-2022 ($ Millions)

Figure 29. APAC Gilenya Sales 2017-2022 (K Units)

Figure 30. APAC Gilenya Revenue 2017-2022 ($ Millions)

Figure 31. Europe Gilenya Sales 2017-2022 (K Units)

Figure 32. Europe Gilenya Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Gilenya Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Gilenya Revenue 2017-2022 ($ Millions)

Figure 35. Americas Gilenya Sales Market Share by Country in 2021

Figure 36. Americas Gilenya Revenue Market Share by Country in 2021

Figure 37. United States Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Gilenya Sales Market Share by Region in 2021

Figure 42. APAC Gilenya Revenue Market Share by Regions in 2021

Figure 43. China Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Gilenya Sales Market Share by Country in 2021

Figure 50. Europe Gilenya Revenue Market Share by Country in 2021

Figure 51. Germany Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Gilenya Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Gilenya Revenue Market Share by Country in 2021

Figure 58. Egypt Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Gilenya Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Gilenya in 2021

Figure 64. Manufacturing Process Analysis of Gilenya

Figure 65. Industry Chain Structure of Gilenya

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390